ArticleThe European respiratory journal2024

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA.

Elizabeth A Cromwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.